SCHEMBL10683725

SCHEMBL10683725

Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)C(C(=O)O)C1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 5/20 0.76
DRD3 P35462 5/20 0.76
CYP3A4 P08684 4/20 0.76
CYP2D6 P10635 4/20 0.76
HTR2A P28223 4/20 0.76
HRH1 P35367 4/20 0.76
OPRK1 P41145 4/20 0.76
SLC6A3 Q01959 4/20 0.76
KCNH2 Q12809 3/20 0.76
MEN1 O00255 3/20 0.76
KMT2A Q03164 3/20 0.76
OPRD1 P41143 3/20 0.76
LMNA P02545 3/20 0.76
ADORA3 P0DMS8 3/20 0.76
SLC29A1 Q99808 2/20 0.76
ADRB1 P08588 2/20 0.76
ADRA2A P08913 2/20 0.76
ADRA2B P18089 2/20 0.76
ADRA2C P18825 2/20 0.76
HTR2B P41595 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10676648 0.93 ADRA1A (0.73) ADRA1ADRD3CYP3A4CYP2D6HTR2A
Hydrochloric Acid SCHEMBL10675752 0.91 ADRA1A (0.71) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10676097 0.91 ADRA1A (0.70) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10681498 0.89 SLC29A1 (0.60) ADRA1ADRD3CYP3A4CYP2D6HTR2A
Cadaverine Tartrate SCHEMBL10675929 0.89 ADRA1A (0.68) ADRA1ADRD3CYP3A4CYP2D6HTR2A
Cadaverine Tartrate SCHEMBL10799297 0.89 ADRA1A (0.68) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10680817 0.87 CYP3A4 (0.67) ADRA1ADRD3CYP3A4CYP2D6HTR2A
Lidoflazine SCHEMBL79037 0.86 ADRA1A (1.00) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10684374 0.85 HTR2A (0.64) ADRA1ADRD3CYP3A4CYP2D6HTR2A
SCHEMBL10683605 0.84 SLC29A1 (0.68) ADRA1ADRD3CYP3A4CYP2D6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed
EP-0068544-B1 NOVEL N-ARYL-PIPERAZINEALKANAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 1987-06-03 EP disclosed
EP-0068544-A2 Novel N-aryl-piperazinealkanamides JANSSEN PHARMACEUTICA N.V. (BE) 1983-01-05 EP disclosed